申请人:Shaman Pharmaceuticals, Inc.
公开号:US05648354A1
公开(公告)日:1997-07-15
Novel 1,2-dithiin compounds useful as antifungal or anti-infective agents, as well as methods for their use as such, are described. The 1,2-dithiin compounds are particularly effective in treating infections, especially those caused by Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, Candida krusei, Candida parapsilosis, Candida tropicalis, Trichophyton rubrum, Epidermophyton species, Microsporum species, Sporothrix species, Blastomyces dermatitidis, Coccidiodes immiitis, Histoplasma capsulatum, Herpes virus, Influenza virus, Cytomegalovirus, human immunodeficiency virus, retrovirus, Adenovirus, Papillomavirus, Paravirus, Arenavirus, Bunyavirus, Coronavirus, Paramyxovirus, Picornavirus, Rhabdovirus, Togavirus, Hepadnavirus, Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella pneumoniae, Staphylococcus epidermis, Zanthomonus maltrophilia, Acinetobacter, Enterobacter cloacae, Serratia marscens, Listeria, Monocytogenes, Enterococcus faecalis, Streptococcus pyogenes; Streptococcus pneumonia, Viridans streptococci, Haemophilus influenzae, Proteus mirabills, Proteus vulgaris and Bacterioides fragilis.
本发明涉及一种用作抗真菌或抗感染剂的新型1,2-二硫杂茂化合物,以及它们的使用方法。这些1,2-二硫杂茂化合物特别有效用于治疗感染病,特别是由白色念珠菌、新型隐球菌、烟曲霉、克鲁氏白色念珠菌、副溶血性链球菌、热带白色念珠菌、红色毛癣菌、表皮癣菌、微孢子菌属、孢子丝菌属、皮肤芽生菌、肺孢子菌、组织胞浆菌、疱疹病毒、流感病毒、巨细胞病毒、人类免疫缺陷病毒、逆转录病毒、腺病毒、乳头状病毒、副黏病毒、布尼病毒、冠状病毒、副粘病毒、钩端螺旋体病毒、肝炎病毒、金黄色葡萄球菌、肠球菌、铜绿假单胞菌、肺炎克雷伯菌、表皮葡萄球菌、烟草芽孢杆菌、肠埃希氏菌、克雷伯氏菌、马尔凯菌、不动杆菌、肠埃氏菌、马氏链球菌、李斯特菌、单核细胞增多症杆菌、肺炎链球菌、绿色链球菌、流感嗜血杆菌、奇异变形杆菌和厌氧梭菌等引起的感染病。